1. Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis. 2007; 45:273–280.
Article
2. Colgan R, Williams M, Johnson JR. Diagnosis and treatment of acute pyelonephritis in women. Am Fam Physician. 2011; 84:519–526.
3. Ki M, Park T, Choi B, Foxman B. The epidemiology of acute pyelonephritis in South Korea, 1997-1999. Am J Epidemiol. 2004; 160:985–993.
Article
4. Sobel JD, Kaye D. Urinary tract infections. In : Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadephia: Elsevier;2015. p. 886–913.
5. Velasco M, Martínez JA, Moreno-Martínez A, Horcajada JP, Ruiz J, Barranco M, Almela M, Vila J, Mensa J. Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary? Clin Infect Dis. 2003; 37:1127–1130.
Article
6. Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R. Are blood cultures necessary in the management of women wih complicated pyelonephritis? J Infect. 2006; 53:235–240.
Article
7. Thanassi M. Utility of urine and blood cultures in pyelonephritis. Acad Emerg Med. 1997; 4:797–800.
Article
8. Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J. Risk factors for community-onset urinary tract infections due to
Escherichia coli harbouring extended-spectrum β-lactamases. J Antimicrob Chemother. 2006; 57:780–783.
Article
9. Naber KG, Savov O, Salmen HC. Piperacillin 2g/tazobactam 0.5g is as effective as imipenem 0.5g/cilastatin 0.5g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections. Int J Antimicrob Agents. 2002; 19:95–103.
Article
10. Talan DA, Stamm WE, Hooton TM, Moran GJ, Burke T, Iravani A, Reuning-Scherer J, Church DA. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA. 2000; 283:1583–1590.
Article
11. Stunell H, Buckley O, Feeney J, Geoghegan T, Browne RF, Torreggiani WC. Imaging of acute pyelonephritis in the adult. Eur Radiol. 2007; 17:1820–1828.
Article
12. Rhee JY, Kwon KT, Ki HK, Shin SY, Jung DS, Chung DR, Ha BC, Peck KR, Song JH. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock. 2009; 31:146–150.
Article
13. Rollino C, Beltrame G, Ferro M, Quattrocchio G, Sandrone M, Quarello F. Acute pyelonephritis in adults: a case series of 223 patients. Nephrol Dial Transplant. 2012; 27:3488–3493.
Article
14. McMurray BR, Wrenn KD, Wright SW. Usefulness of blood cultures in pyelonephritis. Am J Emerg Med. 1997; 15:137–140.
Article
15. Mills AM, Barros S. Are blood cultures necessary in adults with pyelonephritis? Ann Emerg Med. 2005; 46:285–287.
Article
16. Wing DA, Park AS, Debuque L, Millar LK. Limited clinical utility of blood and urine cultures in the treatment of acute pyelonephritis during pregnancy. Am J Obstet Gynecol. 2000; 182:1437–1440.
Article
17. Hsu CY, Fang HC, Chou KJ, Chen CL, Lee PT, Chung HM. The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci. 2006; 332:175–180.
Article
19. Soulen MC, Fishman EK, Goldman SM, Gatewood OM. Bacterial renal infection: role of CT. Radiology. 1989; 171:703–707.
Article
20. Mitterberger M, Pinggera GM, Colleselli D, Bartsch G, Strasser H, Steppan I, Pallwein L, Friedrich A, Gradl J, Frauscher F. Acute pyelonephritis: comparison of diagnosis with computed tomography and contrast-enhanced ultrasonography. BJU Int. 2008; 101:341–344.
Article
21. Abraham G, Reddy YN, George G. Diagnosis of acute pyelonephritis with recent trends in management. Nephrol Dial Transplant. 2012; 27:3391–3394.
Article